TissueLink Versus SEAMGUARD After Distal Pancreatectomy

PHASE4TerminatedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2015

Conditions
Distal Pancreatectomy
Interventions
DEVICE

SEAMGUARD with bioabsorbable staple

In the SEAMGUARD group, pancreatic resection and transection of the pancreatic body will be executed using an endoscopic linear stapling device.

PROCEDURE

TissueLink with radiofrequency ablation

After pancreatic transection with the method of choice of the operating surgeon, the pancreatic remnant will be treated with Tissuelink alone for an ablation depth (thickness) of approximately 7 mm.

Trial Locations (2)

55905

Mayo Clinic, Rochester

02144

Massachusettes General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER